Abstract
Background:
Vitamin D plays a key role in responses of brain-gut axis. It has been suggested that functional dyspepsia (FD) may be associated with decreased levels of vitamin D. Hence this study wished to find the association between vitamin D in patients with FD.
Materials and methods:
This case-control study was done at a tertiary care hospital with 150 cases and 150 controls. FD was diagnosed by the ROME IV criteria. Demographic profile and serum vitamin D levels including Perceived Stress Score (PSS) and salivary amylase were determined for both cases and controls.
Results:
Majority of the FD cases were males (57.3%). Post-prandial distress syndrome represented the major type of FD cases (69.3%). A higher mean BMI was found among the control group (23.2 vs. 21.2, P<0.05) and higher percentage of obese individuals in the control group (42.7% vs. 29.3%, P= 0.05). Majority of the cases are from rural background (89.3% vs. 74%, P<0.001). Comparison of PSS showed that cases had significantly higher grades of PSS than control (P<0.001). However, no significant association was found in the levels of salivary amylase between the groups (P=0.728). Hypovitaminosis D (<30 ng/ml) was found significantly more among cases than controls (73.3% vs. 60%; P<0.05) with an odds ratio of 1.833 (CI 95%= 1.126–2.985). After adjustment of age, place of residence and BMI, vitamin D levels were significantly associated with FD in the regression analysis.
Conclusion:
This study shows significant association of vitamin D deficiency in FD patients. It also opens up new avenues for further research into the role of vitamin D supplementation to further improve the management of such cases.
Keywords: case-control study, functional dyspepsia, vitamin D deficiency
Introduction
Highlights
Close association of vitamin D deficiency, BMI and perceived stress score in functional dyspepsia (FD).
Higher prevalence of vitamin D deficiency in FD.
The design of case-control study helped in correlating the key parameters in FD.
Functional dyspepsia (FD) is an enigma in itself but a commonly prevalent problem, around 10–30%, encountered by physicians worldwide1. Notwithstanding of the fact that the vast facets underlying FD remains under active consideration, still certain areas delving into its etiopathogenesis is wide open. There is evidence of low-grade inflammation in duodenal mucosa including eosinophilic infiltration and T-cell mediated among others2. Since vitamin D has immunomodulatory properties and its role has been well established in various diseases including inflammatory bowel diseases and cancers, evaluation of vitamin D status in patients with FD needs to be actively pursued given its immuno-regulatory attributes3. Irene and his coworkers documented a retrospective study on vitamin abnormalities (low vitamin B1, vitamin B6, 25 -OH vitamin D, zinc and total CoEnzyme Q levels) in patients with gastrointestinal motility and functional intestinal disorders4. Studies have also revealed that vitamin D deficiency (VDD) is prevalent in irritable bowel syndrome patients5. The beneficial roles of vitamin D, particularly in gut and neurological functioning of the body counts in an effective option in treating irritable bowel syndrome5,6. The work by Hari and colleagues proposed the potential involvement of hypoxia-inducible factors in the pathophysiological mechanisms underlying FD. This prospective novel hypothesis established correlation between FD eosinophilia, barrier dysfunction and gut dysbiosis7. Du et al.8 established the links between micro-inflammation and FD. The pathogenesis of FD is characterised by these micro-inflammation like local immune cell infiltration, specifically the eosinophils and mast cells8. Studies established the correlation of low vitamin D levels with gastric adenocarcinoma9, gastric incomplete intestinal metaplasia10, irritable bowel syndrome5,6 and so on, but the interrelation between vitamin D levels with FD is still unknown. In one study, increased vitamin D receptor (VDR) expression is seen in duodenal mucosa and it has been proposed that since vitamin D acts as a ligand of VDR, assessing vitamin D status in such patients remains an area of active research11.
Interestingly, VDD is found to be strongly related with functional problems in intestinal neuromotility12 apart from psychiatric disorders like anxiety and depression, severely affecting the quality of life of the patients13. With the weak pyloric sphincter, food from the small intestines will tend to flow back into the stomach. The bacteria will then ferment the semi-digested food causing gas formation, thereby pressurising the already weakened lower oesophageal sphincter (LES)7. Resultantly, the LES will open backwards causing acidic contents to reflux and subsequently epigastric pain and heartburn—exhibiting a spectrum of FD symptoms14,15. The mechanism of action of calcitriol (the active metabolite of vitamin D (1,25(OH)2 vitamin D)) is mediated by the VDR (subfamily of nuclear receptors) which acts as transcription factors in the target cells post formation of a heterodimer with the retinoid X receptor16,17. This types of receptors are found in all cell types, including oesophagus, stomach and the pyloric sphincter cells in the digestive system18.
Also it has also been seen that chronic stress is increasingly recognised as an aetiological factor, part of brain-gut axis, in the causation of FD19. Although usefulness of psychoactive agents are reported20, but results are not uniform. Salivary alpha amylase activity have been studied and shown as a biomarker of chronic stress in previous studies21. Therefore, for more definite objective evidence with regard to role of stress in the etiopathogenesis and thereby management of FD, measuring salivary alpha amylase activity will be a key milestone in FD research. Keeping in mind all these issues, this study is proposed to delve into the serum vitamin D concentration, Perceived Stress Score (PSS) and salivary alpha amylase activity in FD patients and their association if any. This study is envisaged to further establish or strengthen the etiopathogenesis of FD and this particular study is one of its kind.
Research hypothesis
We wish to seek whether patients with FD is associated with vitamin D deficiency and increased salivary alpha amylase activity.
Objectives of the study
To estimate Vitamin D (25OH vitamin D) concentration and salivary alpha amylase activity and PSS in patients with FD.
To find out the association between patients of FD with VDD and salivary alpha amylase activity.
Methods
The study had been reported in line with the STROCSS criteria22. The registration unique identifying number (UIN) is osf.io/w7fu623.
Study design
It was a case-control study with patients attending medicine out patient department of a tertiary care academic hospital in Eastern India over the period from May 2021 to September 2022.
Selection of cases and controls
All consecutive patients presenting with symptoms of dyspepsia were subjected to history taking, physical examination, recent medical record review and those fulfilling the ROME IV criteria of FD were enroled into the study after fulfilling the below mentioned inclusion and exclusion criteria24. Other coexisting comorbidities were also noted.
The stress severity score was assessed by PSS25.
Healthy controls were selected from subjects attending the hospital for routine health checkup or pre-employment checkup or accompanying patient attendants without any history of self-reported chronic illness.
Inclusion criteria
Age equal to or more than 14 years of age.
Patients fulfilling ROME IV criteria of FD24.
Exclusion criteria
Those having adequate response to antisecretory agents from history.
Those having documented endoscopic evidence of erosions, ulcers, esophagitis.
Patients with comorbidities like Diabetes Mellitus, Chronic Kidney Disease, Chronic Lung Diseases, Chronic liver Disease, Cardiovascular diseases, inflammatory bowel disease any other organic or systemic illness that explains the symptoms.
On chronic non-steroidal anti-inflammatory drugs use, recent vitamin D intake.
Known psychiatric illness undergoing treatment.
Pregnant women.
Measurement of vitamin D and salivary alpha amylase levels
Serum 25—dihydroxyvitamin D was measured by ELISA kit (DIA source Immnunoassay S.A. Belgium). Hypovitaminosis D was taken as 25 (OH)D3 less than 30 ng/ml while moderate to severe deficiency of vitamin D (VDD) taken as 25 (OH)D3 less than 10 ng/ml26–29. Salivary alpha amylase levels were measured with ELISA kit (Fine Test alpha amylase 1 kit). The normal level of salivary amylase range from 27 to 1140 U/ml30.
Statistical plan
Analysis was performed using SPSS version 27.
Categorical variables were summarised as counts and percentages as well as median for ordinal variables. For continuous data mean (SD) were used.
P values were calculated with the use of χ2 test or Fisher’s exact tests, when appropriate and Student’s t-test for continuous variables. For non-normal distribution, Mann–Whitney U test were performed. Normality of the distribution was performed with Kolmogorov–Smirnov test and the Shapiro–Wilk test. Between two groups difference was significant when P value less than 0.05.
To find the predictors associated with FD, multivariate logistic regression analysis was performed.
Sample size calculation
Assuming an equal number of cases and controls and from previous studies, prevalence of VDD among adults to be around 60%27,28, the number of study subjects required to detect an odds ratio (OR) of 2.0 with 0.80 power using a two-sided 0.05 test will be as follows—
Total number of subjects: 304
Number of cases: 152
Number of controls: 152
“citation(\“epiR\“)” using R programming language and software31.
Ethics statement
This study was approved by the Institutional Ethics Committee (IEC) of AIIMS Bhubaneswar vide no. T/IM-F/20-21/17. Written informed consent was collected from all the participants.
Results
A total of 150 cases and 150 controls were included during the study period matched by sex.
Characteristics of FD cases
Post-prandial distress syndrome represented the major type of FD cases (104 cases; 69.3%), followed by epigastric distress syndrome (46 cases, 30.6%). Among the cases, 6.6% had sleep problems, 18.6% had heart burn, 18.6% had bowel disturbances and 13.4% had headache. (Table 1).
Table 1.
Characteristics of functional dyspepsia cases
| Types of FD | N=150), N (%) |
|---|---|
| PDS | 104 (69.3) |
| EPS | 46 (30.6) |
EPS, epigastric pain syndrome; FD, functional dyspepsia; PDS, post-prandial distress syndrome.
Cases and controls comparison
With regards to demographic features, no significant differences were found between controls and cases except for age, place of residence and BMI. Cases have higher mean age than the controls (42.24±12.047 vs. 38.94±13.8, P=0.028). A higher mean BMI was found among the control group (23.2 vs. 21.2, P<0.05) and higher percentage of obese individuals in the control group (42.7% vs. 29.3%, P= 0.05). Majority of the cases are from rural background (89.3% vs. 74%, P<0.001). (Table 2).
Table 2.
Demographic characteristics comparison among cases and controls
| Variables | Cases | Controls | P |
|---|---|---|---|
| Total, n (%) | 150 (100) | 150 (100) | — |
| Sex, n (%) | 0.639 | ||
| Male | 86 (57.3) | 90 (60) | |
| Female | 64 (42.7) | 60 (40) | |
| Age (years), mean SD | 42.2 ± 12.0 | 38.9 ± 13.8 | 0.028 |
| Male | 41.6 ± 12.4 | 40 ± 14.1 | 0.410 |
| Female | 42.9 ± 11.5 | 37.3 ± 13.2 | 0.012 |
| Residence, n (%) | 0.001 | ||
| Rural | 134 (89.3) | 111 (74) | |
| Urban | 16 (10.7) | 39 (26) | |
| No. family members, mean SD | 5.5 ± 3.0 | 5.3 ± 2.4 | 0.921 |
| Educational status, n (%) | 0.119 | ||
| Illiterate | 13 (8.7) | 14 (9.3) | |
| Primary school | 63 (42) | 46 (30.7) | |
| Secondary school and above | 74 (49.3) | 90 (60) | |
| Employment status, n (%) | 1 | ||
| Unemployed | 111 (74) | 112 (74.7) | |
| Employed | 39 (26) | 38 (25.3) | |
| Tobacco use, n (%) | 0.679 | ||
| No | 114 (76) | 118 (78.7) | |
| Yes | 36 (24) | 32 (21.3) | |
| Alcohol use, n (%) | 0.871 | ||
| No | 127 (84.7) | 129 (86) | |
| Yes | 23 (15.3) | 21 (14) | |
| Diet pattern, n (%) | 0.085 | ||
| Veg | 3 (2) | 10 (6.7) | |
| Non-veg | 147 (98) | 140 (93.3) | |
| PSS, n (%) | 0.000 | ||
| High | 21 (14) | 4 (2.7) | |
| Low | 38 (25.3) | 91 (60.7) | |
| Moderate | 91 (60.7) | 55 (36.7) |
Statistically significant values are in bold.
PSS, Perceived Stress Score.
Comparison of PSS showed that cases had significantly higher grades of PSS than control (P<0.001). Moderate to high stress as assessed by PSS scale was higher among cases (60.1% and 14%, respectively) compared to controls (36.7% and 2.7%) (Table 3). However, there is no significant difference in the number of family members between the groups (P>0.05).
Table 3.
Showing comparison of vitamin D levels between cases and controls
| Cases | Controls | P | OR | |
|---|---|---|---|---|
| Vitamin D, mean (ng/ml) SD | 22.9 ± 18.3 | 27.8 ± 17.5 | 0.009 | |
| Vitamin D categories, n (%) | 0.020 | |||
| Hypovitaminosis D | 110 (73.3) | 90 (60) | 1.833 | |
| Normal Vitamin D | 40 (26.7) | 60 (40) |
Statistically significant values are in bold.
OR, odds ratio.
Association of vitamin D and FD
Cases had significantly lower mean vitamin D levels compared to controls (22.92 vs. 27.85 ng/ml; P < 0.009). Hypovitaminosis D (<30 ng/ml) was found significantly more among cases (73.3% vs. 60%; P < 0.05) with an OR of 1.833 (CI 95%= 1.126–2.985). Table 3.
VDD (<10 ng/ml) was found significantly more among cases (23.3% vs. 12.7%; P < 0.005). Females in the case group had significantly higher Hypovitaminosis D than those in control group (79.7% vs. 63.3%; P = 0.048) with OR of 2.271. However, there is no such significant difference between the males (68.6% vs. 57.8%; P = 0.161). Table 4.
Table 4.
Hypovitaminosis D as per sex among functional dyspepsia and controls
| Hypovitaminosis D, n (%) | Cases | Controls | P | OR |
|---|---|---|---|---|
| Males | 59 (68.6) | 52 (57.8) | 0.161 | |
| Females | 51 (79.7) | 38 (63.3) | 0.048 | 2.271 |
| Vitamin D level (<10ng/ml), n (%) | 35 (23.3) | 19 (12.7) | 0.005 | |
| Vitamin D mean (ng/ml) SD | ||||
| Males | 24.4 ± 18.6 | 29.2 ± 18.7 | 0.091 | |
| Females | 20.8 ± 17.8 | 25.7 ± 15.5 | 0.107 | |
Statistically significant values are in bold.
OR, odds ratio.
Association between salivary alpha amylase and FD
There was no significant difference between the mean levels of salivary alpha amylase between the cases and control. Table 5.
Table 5.
Showing mean SAA levels between the cases and control
| Levels of SAA, u/ml SD | Cases | Controls | P |
|---|---|---|---|
| Mean value | 5.032 ± 1.73 | 6.232 ± 1.79 | 0.728 |
SAA, salivary alpha amylase.
Effect of BMI on serum vitamin D concentration in FD vs. controls
Serum vitamin D was significantly higher in the overweight controls than overweight FD subjects (33.2 vs. 21.2, P = 0.009). Serum vitamin D concentration was similar between normal and obese cases and controls (P>0.05) Figure 1.
Figure 1.

Boxplot showing comparison of vitamin D levels between functional dyspepsia and controls stratified by BMI.
Predictors of FD
In the regression analysis, age, place of residence, BMI and vitamin D levels have been found to be the predictors of FD. After adjustment of age, place of residence and BMI, vitamin D levels were significantly associated with FD. (Table 6).
Table 6.
Predictors of FD
| Variables | B coefficient | S.E. | Wald | df | Sig | OR |
|---|---|---|---|---|---|---|
| Age (years) | −0.018 | 0.009 | 3.444 | 1 | 0.063 | |
| Residence | −0.939 | 0.333 | 7.949 | 1 | 0.005 | |
| BMI | 0.035 | 4.630 | 1 | 0.031 | 0.031 | |
| Vitamin D (ng/ml) | 0.016 | 0.007 | 5.146 | 1 | 0.023 | 1.016 |
| Model summary | ||||||
| Step | −2 Log likelihood | Cox & Snell R Square | Nagelkerke R Square | |||
| 389.824 | 0.083 | 0.111 | ||||
Statistically significant values are in bold.
FD, functional dyspepsia; OR, odds ratio; Sig, significance.
Nagelkerke R Square= 11%, P= 0.023, OR= 1.016.
Discussion
In our cohort of cases and controls, the primary finding is the significant higher prevalence of hypovitaminosis D or VDD in FD patients relative to that of controls. Although the sedentary lifestyle habits, irregular meal patterns and fast eating rates account for the prevalence of hypovitaminosis D or for that matter VDD in normal population, the self-limited or restricted dietary food choices (non-pharmacological management strategy to relieve unpleasant sensations in gastrointestinal region) in the FD patients might account for the higher prevalence of VDD in cases as compared to the controls. The impact of VDD in FD patients can be understood from the different studies. Dr. Walter Stumpf studied Vitamin D and outlined the impact of VDRs on oesophagus, stomach and the pyloric sphincter cells in the digestive system32. As vitamin D is vital for the functioning of muscle cells; the VDD in the body thus can impair the functioning of the muscle cells (including the LES and pyloric sphincter) guarding the lower end of the stomach which opens to the small intestines32,33. Studies have also firmly posits the association of lower vitamin D levels with gastric adenocarcinoma9, gastric incomplete intestinal metaplasia10 and irritable bowel syndrome5,6 .
We did not find significant association with regards to consumption of alcohol or tobacco between the cases and control. This might be because of the characteristics of the population in this part of the region as evident by the low percentage of cases as well as controls consuming alcohol or using tobacco thereby giving a too low a sample to find a significant effect.
We also did not find any significant association of salivary amylase between the cases and controls. This might be because of overall decrease in salivary amylase in fasting state34. As our population in this part of the region visit the tertiary care centre from far flung areas to make an out patient department visit, they usually prefer to stay fasting overnight till all the necessary investigations are done. Moreover, studies have shown decrease in salivary alpha amylase in the morning hours (circadian rhythm)35. Also, salivary amylase may be more increased in acute stress than in chronic stress in addition to the above mentioned possible factors36.
The BMI was found to be slightly higher in the controls as compared to the cases (FD patients). This may be because of eating disorders of the FD patients or their reluctancy to avoid food as it tends to precipitate the symptoms. Studies reported positive association of functional gastrointestinal disorders, globus and regurgitation with BMI (including obesity) in patients residing in Europe, Latin American countries and United States37,38. However, studies in the Asian population exhibited an inverse relationship between FD and BMI39–41. Low BMI may lead to FD via visceral hypersensitivity and delayed gastric emptying due to activation of corticotrophin-releasing factor receptors41. The difference in two groups of studies is in line with the BMI differences between the Asian and Caucasian populations42. Our study thus is in line with the findings of the above literatures.
For measurement of stress, the PSS is among the psychological scoring instrument widely used25. In our study, the FD patients scored higher for PSS as compared to the controls. The study highlighted the significant role (higher PSS score) of stress in the development of FD. This may be attributed to the discomfort or unpleasant sensation of FD which causes stress elevation and in turn high PSS score. Higher PSS score is strongly associated with poor or impaired quality of life of the FD patients as compared to the controls. Equally, the significantly elevated PSS score and VDD in FD patients is in line with other studies43,44. The intrinsic role of psychiatric disorders and psychosocial factors, more particularly anxiety and depression has been documented by other research groups in the etiopathogenesis of FD. The association of stress with the activation of the hypothalamus releases corticotrophin-releasing factor, with significant mast cell activation (inflammation), activation of the sympathetic nervous system apart from altered gastric accommodation, gastric dysmotility, and visceral hypersensitivity45. Also FD is a common gut-brain interaction disorder. An imbalanced gut microbiota may lead to short chain fatty acid profile and bile acid pool alterations, thus consequently dysregulating cellular stress response pathways in FD (like hypoxia-inducible factor)46,47. Further the eating disorders of FD patients are often linked with anxiety neurosis (accounting for high PSS score) and a key factor associated with low BMI48,49. In other words, the dietary restrictions owing to persistent manifestation of FD symptoms may have resulted in low BMI and elevated PSS score in FD patients. This fact is corroborated with the cross-sectional study by Beh et al. 40. The authors take the opportunity to caution about the unbalanced, improvised and self-controlled exclusion diets which may enhance anxiety and visceral hyperalgesia.
The findings of the study also presented rural population exhibiting higher FD symptoms as compared to the urban ones. This may be likely because of the preference of the urban population to consult private healthcare and an inclination towards self-medication (purchasing of over-the-counter drugs). This is consistent with other population-based studies50,51.
The study however reports absence of significant correlation between FD patients and epidemographic factors including age, sex, educational status or occupation. This lack of relationship may be due to the functional nature of FD. These findings are consistent with previous documented studies52,53. The study further could not find significant changes in the salivary alpha amylase values between the cases and controls. The inconsistent association of FD with smoking or alcohol intake was also consistent with the findings of Shaib and El-Seraj and Khademolhosseini et al. 54,55. The vegetarian or non-vegetarian diets were found to have no significant effect on FD patients. This fact is further supported by a study on Indian population where FD symptoms were independent of type of diet but the intake of spicy and fried foods consumed from outside the home contributed in insignificantly worsening of the FD symptoms56.
Strengths and limitations
The strength of this work remains in the designing of the study as case-control study with an objective of probing into the VDD in FD patients, which helped correlating the key parameters in FD cases to comparable parameters in the controls by addressing the potential confounders. Moreover, the study seems to be a beacon in the dark as it has practical applications in the form of therapeutic armamentarium. However, the study has its limitations as well. The variations in salivary alpha amylase stress response, appropriateness of saliva collection and non-assessment of the micronutrient deficiency of the FD patients accounts for major limitations of this study.
Conclusion
In summary, the present work demonstrates a close association of VDD, BMI and PSS score in FD patients for the first time. In this study, a higher prevalence of VDD was found in FD patients as compared to the controls. The findings of this study also showed a difference in rural and urban population exhibiting FD symptoms. To the best of our knowledge, current literature review has shown association of vitamin D with inflammatory bowel disease and but no studies were conducted assessing the association of FD with VDD. Self-restrictive diet accounted for the low BMI of the FD patients, which in turn attenuated the PSS score.
Findings from the study has been able to shed light into the role of vitamin D in FD and the possible need for vitamin D supplementation to further improve the management of such cases, thus opening new avenues for further research. As management of FD is still a conundrum, this research findings of this study is envisaged to find a place in effective management of FD patients. Further in this respect, a randomised double-blinded placebo-controlled trial on the supplementation of vitamin D is planned to support this observational study. The choice of optimum vitamin D supplementation dose and improvement in the quality of life post vitamin D supplementation will also be delved into.
Ethical approval
This study was approved by the Institutional Ethics Committee (IEC) of AIIMS Bhubaneswar vide no. T/IM-F/20-21/17.
Consent
Written informed consent was obtained for all participants for publication and any accompanying images and that copies of the written consent are available on request. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request. If any participants were minors, written informed consent was obtained from their parents/legal guardians. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request.
Source of funding
This study was funded by All India Institute of Medical Sciences (AIIMS), Bhubaneswar, India. The sponsor has no role in collection, analysis and interpretation of data.
Author contribution
D.S.D.—study concept and design, data collection, data analysis and interpretation. G.K.S.—sample analysis for vitamin D and alpha amylase estimation. M.K.P.—data collection, critical analysis and review of the manuscript. D.S.—data collection and review of the manuscript. All authors have approved the final manuscript.
Conflicts of interest disclosure
The authors declare that they have no conflicts of interest.
Research registration unique identifying number (UIN)
Registration DOI: https://doi.org/10.17605/OSF.IO/RNQHF OSF Registries osf.io/w7fu6.
Guarantor
Dr. Dhriti Sundar Das.
Data availability statement
No dataset is available publicly currently.
Provenance and peer review
Not invited.
Footnotes
Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.
Published online 16 August 2023
Contributor Information
Dhriti Sundar Das, Email: genmed_dhriti@aiimsbhubaneswar.edu.in.
Gautom Kumar Saharia, Email: biochem_gautom@aiimsbhubaneswar.edu.in.
Manas Kumar Panigrahi, Email: medgast_manas@aiimsbhubaneswar.edu.in.
Debananda Sahoo, Email: genmed_debananda@aiimsbhubaneswar.edu.in.
References
- 1.Talley NJ, Ford AC. Functional dyspepsia. N Engl J Med 2015;373:1853–1863. [DOI] [PubMed] [Google Scholar]
- 2.Romano C, Valenti S, Cardile S, et al. Functional dyspepsia: an enigma in a conundrum. J Pediatr Gastroenterol Nutr 2016;63:579–584. [DOI] [PubMed] [Google Scholar]
- 3.Athanassiou L, Mavragani CP, Koutsilieris M. The immunomodulatory properties of vitamin D. Mediterr J Rheumatol 2022;33:7–13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Sonu I, Wang L, Zia J, et al. Vitamin abnormalities in patients with gastrointestinal motility and functional disorders: 1768. Off J Am College Gastroenterol ACG 2015;110:S751–S752. [Google Scholar]
- 5.Barbalho SM, Goulart RA, Araújo AC, et al. Irritable bowel syndrome: a review of the general aspects and the potential role of vitamin D. Expert Rev Gastroenterol Hepatol 2019;13:345–359. [DOI] [PubMed] [Google Scholar]
- 6.Abbasnezhad A, Amani R, Hajiani E, et al. Effect of vitamin D on gastrointestinal symptoms and health-related quality of life in irritable bowel syndrome patients: a randomized double-blind clinical trial. Neurogastroenterol Motil 2016;28:1533–1544. [DOI] [PubMed] [Google Scholar]
- 7.Hari S, Burns GL, Hoedt EC, et al. Eosinophils, hypoxia-inducible factors, and barrier dysfunction in functional dyspepsia. Front Allergy 2022;3:851482. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Du L, Shen J, Kim JJ, et al. Increased duodenal eosinophil degranulation in patients with functional dyspepsia: a prospective study. Sci Rep 2016;6:34305. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Mahendra A, Karishma, Choudhury BK, et al. Vitamin D and gastrointestinal cancer. J Lab Physicians 2018;10:1–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Singh K, Gandhi S, Batool R. A case-control study of the association between vitamin D levels and gastric incomplete intestinal metaplasia. Nutrients 2018;10:629. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Stanghellini V. Functional dyspepsia and irritable bowel syndrome: beyond Rome IV. Dig Dis 2017;35(suppl 1):14–17. [DOI] [PubMed] [Google Scholar]
- 12.Mărginean CO, Meliţ LE, Borka Balas R, et al. The crosstalk between vitamin D and pediatric digestive disorders. Diagnostics (Basel) 2022;12:2328. doi: 10.3390/diagnostics12102328. Published online 2022 Sep 27. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Bicikova M, Duskova M, Vitku J, et al. Vitamin D in anxiety and affective disorders. Physiol Res 2015;64:S101. [DOI] [PubMed] [Google Scholar]
- 14.Rohof W, Hirsch D, Boeckxstaens G. Pathophysiology and management of gastroesophageal reflux disease. Minerva Gastroenterol E Dietol 2009;55:289–300. [PubMed] [Google Scholar]
- 15.Van Herwaarden M, Samsom M, Rydholm H, et al. The effect of baclofen on gastro‐oesophageal reflux, lower oesophageal sphincter function and reflux symptoms in patients with reflux disease. Aliment Pharmacol Ther 2002;16:1655–1662. [DOI] [PubMed] [Google Scholar]
- 16.Issa L, Leong G, Eisman J. Molecular mechanism of vitamin D receptor action. Inflamm Res 1998;47:451–475. [DOI] [PubMed] [Google Scholar]
- 17.Dusso AS, Thadhani R, Slatopolsky E. Vitamin D receptor and analogs. Semin Nephrol 2004;24:10–16. [DOI] [PubMed] [Google Scholar]
- 18.Gil Á, Plaza-Diaz J, Mesa MD. Vitamin D: classic and novel actions. Ann Nutr Metab 2018;72:87–95. [DOI] [PubMed] [Google Scholar]
- 19.Addula M, Wilson VE, Reddymasu S, et al. Immunopathological and molecular basis of functional dyspepsia and current therapeutic approaches. Expert Rev Clin Immunol 2018;14:831–840. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Adamson J, Lally J, Gaughran F, et al. Correlates of vitamin D in psychotic disorders: a comprehensive systematic review. Psychiatry Res 2017;249:78–85. [DOI] [PubMed] [Google Scholar]
- 21.Vanheel H, Farré R. Changes in gastrointestinal tract function and structure in functional dyspepsia. Nat Rev Gastroenterol Hepatol 2013;10:142–149. [DOI] [PubMed] [Google Scholar]
- 22.Mathew G, Agha R, Albrecht J, et al. STROCSS 2021: Strengthening the reporting of cohort, cross-sectional and case-control studies in surgery. Int J Surg 2021;96:106165. [DOI] [PubMed] [Google Scholar]
- 23.DAS DS. Evaluation of Vitamin D status and salivary amylase activity in patients with functional dyspepsia- A case control study. Accessed 14 June, 2023, 10.17605/OSF.IO/RNQHF [DOI]
- 24.ROME FOUNDATION. Accessed 10 June, 2023. https://theromefoundation.org/wp-content/uploads/Rome-Foundation-Diagnostic-Criteria-Booklet-2019.pdf
- 25.Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. Journal of health and social behavior. 1983:385–96. [PubMed]
- 26.Gani LU, How CH. Vitamin D deficiency. Singapore Med J 2015;56:433. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266–281. [DOI] [PubMed] [Google Scholar]
- 28.Thomas MK, Lloyd-Jones DM, Thadhani RI, et al. Hypovitaminosis D in medical inpatients. N Engl J Med 1998;338:777–783. [DOI] [PubMed] [Google Scholar]
- 29.Electrochemiluminescence Assay for Quantitative Determination of total 25-OH Vitamin D in Human Serum. Accessed 15 July, 2023, https://www.tulipgroup.com/PDFs/Elisa_Chemi/IFU/Electra-25-OH-Vitamin-D-IFU.pdf
- 30.Ashok L, Sujatha G, Hema G. Estimation of salivary amylase and total proteins in leukemia patients and its correlation with clinical feature and radiographic finding. Indian J Dental Res 2010;21:486. [DOI] [PubMed] [Google Scholar]
- 31.R Programming language. https://cran.r-project.org/web/packages/epiR/index.html
- 32.Stumpf WE. Vitamin D and the digestive system. Eur J Drug Metab Pharmacokinet 2008;33:85–100. [DOI] [PubMed] [Google Scholar]
- 33.Stumpf WE. Vitamin D sites and mechanisms of action: a histochemical perspective. Reflections on the utility of autoradiography and cytopharmacology for drug targeting. Histochem Cell Biol 1995;104:417–427. [DOI] [PubMed] [Google Scholar]
- 34.Johansson I, Ericson T, Steen L. Studies of the effect of diet on saliva secretion and caries development: the effect of fasting on saliva composition of female subjects. J Nutr 1984;114:2010–2020. [DOI] [PubMed] [Google Scholar]
- 35.Nater UM, Rohleder N, Schlotz W, et al. Determinants of the diurnal course of salivary alpha-amylase. Psychoneuroendocrinology 2007;32:392–401. [DOI] [PubMed] [Google Scholar]
- 36.Hensten AJN. Salivary alpha amylase as a stress biomarker. OSP J Dent Sci 1: JDS-1-103 2019;1:103–108. [Google Scholar]
- 37.Bouchoucha M, Fysekidis M, Julia C, et al. Body mass index association with functional gastrointestinal disorders: differences between genders. Results from a study in a tertiary center. J Gastroenterol 2016;51:337–345. [DOI] [PubMed] [Google Scholar]
- 38.Le Pluart D, Sabaté JM, Bouchoucha M, et al. Functional gastrointestinal disorders in 35 447 adults and their association with body mass index. Aliment Pharmacol Ther 2015;41:758–767. [DOI] [PubMed] [Google Scholar]
- 39.Matsuzaki J, Suzuki H, Asakura K, et al. Classification of functional dyspepsia based on concomitant bowel symptoms. Neurogastroenterol Motil 2012;24:325–e164. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Beh KH, Chuah KH, Rappek NAM, et al. The association of body mass index with functional dyspepsia is independent of psychological morbidity: a cross-sectional study. PLoS ONE 2021;16:e0245511. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Yamamoto Y, Furukawa S, Watanabe J, et al. Association between body mass index and functional dyspepsia in young Japanese people. J Neurogastroenterol Motil 2022;28:276. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Deurenberg P, Deurenberg‐Yap M, Guricci S. Asians are different from Caucasians and from each other in their body mass index/body fat per cent relationship. Obes Rev 2002;3:141–146. [DOI] [PubMed] [Google Scholar]
- 43.Ataie-Jafari A, Qorbani M, Heshmat R, et al. The association of vitamin D deficiency with psychiatric distress and violence behaviors in Iranian adolescents: the CASPIAN-III study. J Diabetes Metab Disord 2015;14:1–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Gracious BL, Finucane TL, Friedman-Campbell M, et al. Vitamin D deficiency and psychotic features in mentally ill adolescents: a cross-sectional study. BMC Psychiatry 2012;12:1–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Rosen JM, Cocjin JT, Schurman JV, et al. Visceral hypersensitivity and electromechanical dysfunction as therapeutic targets in pediatric functional dyspepsia. World J Gastrointest Pharmacol Ther 2014;5:122. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Silva YP, Bernardi A, Frozza RL. The role of short-chain fatty acids from gut microbiota in gut-brain communication. Front Endocrinol 2020;11:25. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Ridlon JM, Kang DJ, Hylemon PB, et al. Bile acids and the gut microbiome. Curr Opin Gastroenterol 2014;30:332. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Sato Y, Fukudo S. Gastrointestinal symptoms and disorders in patients with eating disorders. Clin J Gastroenterol 2015;8:255–263. [DOI] [PubMed] [Google Scholar]
- 49.Martín J, Arostegui I, Loroño A, et al. Anxiety and depressive symptoms are related to core symptoms, general health outcome, and medical comorbidities in eating disorders. Eur Eating Disord Rev 2019;27:603–613. [DOI] [PubMed] [Google Scholar]
- 50.Mahadeva S, Yadav H, Everett S, et al. Factors influencing dyspepsia‐related consultation: differences between a rural and an urban population. Neurogastroenterol Motil 2011;23:846–853. [DOI] [PubMed] [Google Scholar]
- 51.Hu W, Wong WM, Lam C, et al. Anxiety but not depression determines health care‐seeking behaviour in Chinese patients with dyspepsia and irritable bowel syndrome: a population‐based study. Aliment Pharmacol Ther 2002;16:2081–2088. [DOI] [PubMed] [Google Scholar]
- 52.Pappa HM, Grand RJ, Gordon CM. Report on the vitamin D status of adult and pediatric patients with inflammatory bowel disease and its significance for bone health and disease. Inflamm Bowel Dis 2006;12:1162–1174. [DOI] [PubMed] [Google Scholar]
- 53.Haycox TE A, Eggleston A. The health economic impact of upper gastrointestinal symptoms in the general population: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST). Scand J Gastroenterol 1999;34:38–47. [DOI] [PubMed] [Google Scholar]
- 54.Shaib Y, El-Serag HB. The prevalence and risk factors of functional dyspepsia in a multiethnic population in the United States. Off J Am College Gastroenterol ACG 2004;99:2210–2216. [DOI] [PubMed] [Google Scholar]
- 55.Khademolhosseini F, Mehrabani D, Zare N, et al. Prevalence of dyspepsia and its correlation with demographic factors and lifestyle in Shiraz, southern Iran. Middle East J Digest Dis 2010;2:24. [PMC free article] [PubMed] [Google Scholar]
- 56.Shah SS, Bhatia SJ, Mistry FP. Epidemiology of dyspepsia in the general population in Mumbai. Indian J Gastroenterol 2001;20:103–106. [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
No dataset is available publicly currently.
